Effient News and Research

RSS
HCRI completes enrollment in dual antiplatelet therapy clinical trial

HCRI completes enrollment in dual antiplatelet therapy clinical trial

FDA approves AstraZeneca's anti-clotting drug Brilinta

FDA approves AstraZeneca's anti-clotting drug Brilinta

Accumetrics' VerifyNow P2Y12 Test receives CE mark approval for prognostic use

Accumetrics' VerifyNow P2Y12 Test receives CE mark approval for prognostic use

ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI

ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI

Portola, Accumetrics sign agreement to develop and supply VerifyNow System

Portola, Accumetrics sign agreement to develop and supply VerifyNow System

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events

GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

Dual antiplatelet therapy study expanded into Australia and New Zealand

Dual antiplatelet therapy study expanded into Australia and New Zealand

Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation

Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation

Accumetrics secures $24 million in capital infusion

Accumetrics secures $24 million in capital infusion

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

First complete sample-to-result, point-of-care DNA testing system for personalized medicine

First complete sample-to-result, point-of-care DNA testing system for personalized medicine

New report compares efficacy of Plavix, Effient in treating patients with ACS

New report compares efficacy of Plavix, Effient in treating patients with ACS

Daiichi Sankyo, Eli Lilly respond to ACCF/AHA clinical alert on FDA's clopidogrel boxed warning

Daiichi Sankyo, Eli Lilly respond to ACCF/AHA clinical alert on FDA's clopidogrel boxed warning

DAPT Study expands into seven countries in the EU: HCRI

DAPT Study expands into seven countries in the EU: HCRI

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Accumetrics completes enrollment phase of GRAVITAS clinical trial

Accumetrics completes enrollment phase of GRAVITAS clinical trial

TRITON-TIMI 38 study evaluates response rates in patients with common genetic variant in ABCB1 gene

TRITON-TIMI 38 study evaluates response rates in patients with common genetic variant in ABCB1 gene

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results